ORAMED PHARMACEUTICALS INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-21.2M | $-21.6M | $375.0K | $2.7M |
| FY2022 | $-27.9M | $-28.4M | $496.0K | $11.5M |
| FY2023 | $-10.3M | $-10.5M | $254.0K | $4.2M |
| FY2024 | $-8.4M | $-8.4M | $18.0K | $4.1M |
| FY2025 | $-9.1M | $-9.2M | $9.0K | $6.0M |